Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gabapentin for Chronic Refractory Cancer Cough.

Literature DB >> 26962287

Gabapentin for Chronic Refractory Cancer Cough.

Shrikant Atreya¹, Gaurav Kumar¹, Soumitra Shankar Datta¹.

Abstract

Vagal sensory neuropathy or vagal hypersensitivity has been implicated in the pathophysiology of chronic cough. Earlier reports have shown gabapentin to be effective in sensory laryngeal neuropathy and symptom conditions that have a proven neural origin. We present a case report of a patient with chronic refractory cough due to a soft tissue mass in the lung that caused compression of the mediastinal structures. The patient was successfully treated with gabapentin with reduction in the cough intensity, duration, and frequency.

Entities: Chemical Disease Species

Keywords: Cancer; Gabapentin; Refractory cough

Year: 2016 PMID： 26962287 PMCID： PMC4768457 DOI： 10.4103/0973-1075.173940

Source DB: PubMed Journal: Indian J Palliat Care ISSN： 0973-1075

11 in total

1. Gabapentin in the treatment of intractable idiopathic chronic cough: case reports.

Authors: Sheldon Mintz; Jason K Lee
Journal: Am J Med Date: 2006-05 Impact factor: 4.965

2. Chronic refractory cough as a sensory neuropathy: evidence from a reinterpretation of cough triggers.

Authors: Anne E Vertigan; Peter G Gibson
Journal: J Voice Date: 2010-11-04 Impact factor: 2.009

3. Toxicity and response criteria of the Eastern Cooperative Oncology Group.

Authors: M M Oken; R H Creech; D C Tormey; J Horton; T E Davis; E T McFadden; P P Carbone
Journal: Am J Clin Oncol Date: 1982-12 Impact factor: 2.339

4. Analgesic action of gabapentin on chronic pain in the masticatory muscles: a randomized controlled trial.

Authors: Pablo Kimos; Catherine Biggs; Jennifer Mah; Giseon Heo; Saifudin Rashiq; Norman M R Thie; Paul W Major
Journal: Pain Date: 2006-10-09 Impact factor: 6.961

Review 5. Unexplained (idiopathic) cough: ACCP evidence-based clinical practice guidelines.

Authors: Melvin R Pratter
Journal: Chest Date: 2006-01 Impact factor: 9.410

6. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ).

Authors: S S Birring; B Prudon; A J Carr; S J Singh; M D L Morgan; I D Pavord
Journal: Thorax Date: 2003-04 Impact factor: 9.139

Review 1. The efficacy of specific neuromodulators on human refractory chronic cough: a systematic review and meta-analysis.

Authors: Weili Wei; Ruilin Liu; Yangzi ZhangTong; Zhongmin Qiu
Journal: J Thorac Dis Date: 2016-10 Impact factor: 2.895

2. Management of chronic unexplained cough.

Authors: Mohamed S Al-Hajjaj
Journal: Ann Thorac Med Date: 2017 Jan-Mar Impact factor: 2.219

2 in total

Gabapentin for Chronic Refractory Cancer Cough.

1. Gabapentin in the treatment of intractable idiopathic chronic cough: case reports.

2. Chronic refractory cough as a sensory neuropathy: evidence from a reinterpretation of cough triggers.

3. Toxicity and response criteria of the Eastern Cooperative Oncology Group.

4. Analgesic action of gabapentin on chronic pain in the masticatory muscles: a randomized controlled trial.

Review 5. Unexplained (idiopathic) cough: ACCP evidence-based clinical practice guidelines.

6. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ).

7. Chronic cough as a sign of laryngeal sensory neuropathy: diagnosis and treatment.

8. Opiate therapy in chronic cough.

Review 9. Important drugs for cough in advanced cancer.

10. Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial.

Review 1. The efficacy of specific neuromodulators on human refractory chronic cough: a systematic review and meta-analysis.

2. Management of chronic unexplained cough.